CEOs need to be wary of exactly how much they can expect from advancements in the capabilities of the underlying batteries themselves and make sure their R&D honchos are playing it straight with them.
How Derma Sciences’ Edward J. Quilty turned a one-product wonder into a dominant player in its field
How does BioSante, a small pharmaceutical company that took in $2.5 million in revenue in 2010, expect to compete in the multi-billion dollar pharma industry? By being patient, outlasting the pharma giants, and introducing a new drug to fill a gap in the market.
For the Mondavi brothers, the cup is definitely half full.
Where did the Edsel, the Chevette, and more recently the Aztec and Phaeton come from?Certainly not the customer, but more likely from a committee...
Most customers don't really know what they want next, but one thing is for sure - they have a list of problems that they...
Bose says it's been able to innovate better than public companies.